These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2869703)

  • 21. Alprazolam in the treatment of panic disorders.
    Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
    J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alprazolam treatment for panic disorders.
    Alexander PE; Alexander DD
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV; Coleman JH; Greenblatt DJ; Jones KJ; Levine PH; Orsulak PJ; Peterson M; Schildkraut JJ; Uzogara E; Watkins D
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Possible mechanisms for lactate's induction of panic.
    Liebowitz MR; Gorman JM; Fyer A; Dillon D; Levitt M; Klein DF
    Am J Psychiatry; 1986 Apr; 143(4):495-502. PubMed ID: 3953891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    Carr DB; Sheehan DV; Surman OS; Coleman JH; Greenblatt DJ; Heninger GR; Jones KJ; Levine PH; Watkins WD
    Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL
    J Psychiatr Res; 1990; 24 Suppl 2():27-41. PubMed ID: 1980697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacotherapeutic considerations in anxiety disorders.
    Hollister LE
    J Clin Psychiatry; 1986 Jun; 47 Suppl():33-6. PubMed ID: 2872208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Ballenger JC
    J Psychiatr Res; 1990; 24 Suppl 2():15-25. PubMed ID: 1980694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
    Herman JB; Brotman AW; Rosenbaum JF
    J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
    Tesar GE
    J Clin Psychiatry; 1990 May; 51 Suppl():4-10; discussion 50-3. PubMed ID: 1970816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuation treatment of panic disorder with high-potency benzodiazepines.
    Davidson JR
    J Clin Psychiatry; 1990 Dec; 51 Suppl A():31-7. PubMed ID: 2258375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panic disorder: response to sodium lactate and treatment with antidepressants.
    Rifkin A; Siris SG
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(1):33-8. PubMed ID: 3887490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacology of the anxiety disorders.
    Ballenger JC
    Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New proposals for the development of the concepts of neurotic anxiety, major depression and panic attack].
    Xhenseval B
    Acta Psychiatr Belg; 1985; 85(4):480-508. PubMed ID: 2865869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benzodiazepines in panic disorder and agoraphobia.
    Sheehan DV
    J Affect Disord; 1987; 13(2):169-81. PubMed ID: 2890678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic utility of lactate sensitivity in panic disorder.
    Cowley DS; Arana GW
    Arch Gen Psychiatry; 1990 Mar; 47(3):277-84. PubMed ID: 2407210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panic disorders: clinical update 1984. Neuroendocrine aspects.
    Rubin RT
    Psychosomatics; 1984 Oct; 25(10 Suppl):21-6. PubMed ID: 6390481
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased anxiogenic effects of caffeine in panic disorders.
    Charney DS; Heninger GR; Jatlow PI
    Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.